| 6J21 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | GBQ, OLC | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography., Chen S, Lu M, Liu D, Yang L, Yi C, Ma L, Zhang H, Liu Q, Frimurer TM, Wang MW, Schwartz TW, Stevens RC, Wu B, Wuthrich K, Zhao Q, Nat Commun. 2019 Feb 7;10(1):638. doi: 10.1038/s41467-019-08568-5. PMID:30733446 | ||||||||||||||
| Data retrieval |
![]() |
| View 6J21 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |